HB 2369 amends Kansas pharmacy law to expand and clarify the scope of pharmacy practice as it relates to immunizations. The bill expressly includes the ordering and administering of vaccines pursuant to a vaccination protocol as part of the “practice of pharmacy,” and it specifies that pharmacists may administer FDA-approved or authorized vaccines to persons at least seven years of age, or the age recommended by the CDC, whichever is older. It also lists certain vaccines that may be administered under a protocol, including cholera, monkeypox, Japanese encephalitis, typhoid, rabies, yellow fever, tick-borne encephalitis, anthrax, tuberculosis, dengue, Hib, polio, rotavirus, smallpox, and vaccines approved after January 1, 2023 under Board of Pharmacy rules.
The bill also revises related definitions and language in the pharmacy act, including collaborative drug therapy management and collaborative practice agreements, while preserving limits that pharmacists may not independently diagnose, treat disease, or practice medicine and surgery. It maintains the existing framework that pharmacists may work under physician supervision and written agreements, and it clarifies that the bill does not add new registration or permit requirements under the pharmacy act.
The bill’s legal impact is to broaden the authority of Kansas pharmacists and pharmacies to provide vaccinations, especially in settings where access to immunization services may be limited. It affects the Kansas pharmacy act, K.S.A. 2024 Supp. 65-1626a, and would likely influence pharmacists, physicians, pharmacies, patients, and public health vaccination efforts by making pharmacist-administered vaccines more clearly authorized under state law.
Overall sentiment appears supportive and practical, with the bill originating from the House Committee on Health and Human Services and requested by the Kansas Association of Chain Drugstores. The available record does not show recorded opposition, committee debate, or votes, but the bill’s purpose suggests a generally favorable view toward expanding vaccine access through pharmacists.
Notable points of contention, based on the bill text, would likely center on the scope of pharmacist authority, the use of vaccination protocols, and the age threshold for vaccinating children. Any concerns would most likely come from questions about patient safety, physician oversight, and whether certain vaccines should be administered in pharmacies rather than in traditional clinical settings. However, no specific objections are documented in the provided materials.
HB 2369 amends K.S.A. 2024 Supp. 65-1626a in the Kansas pharmacy act to expressly authorize pharmacists to administer certain vaccines under a vaccination protocol and to define that activity as part of the practice of pharmacy. It also updates related collaborative practice language while preserving limits on independent diagnosis, treatment, and prescribing. The bill would affect pharmacists, pharmacies, physicians, and patients by expanding access to immunizations and clarifying the legal authority for pharmacist-administered vaccines.
The available context suggests a generally favorable and noncontroversial reception. The bill was requested by the Kansas Association of Chain Drugstores and referred through the House Committee on Health and Human Services, indicating support from pharmacy stakeholders and a public-health-oriented rationale. No committee transcript, recorded vote, or formal opposition is provided, so there is no evidence of significant recorded resistance in the materials supplied.
The main policy questions raised by the bill are the extent of pharmacist authority to vaccinate, the requirement that vaccines be given pursuant to a protocol, and the minimum age for administration to children. Potential critics could argue about patient safety, training, and whether physician oversight is sufficient, while supporters would emphasize access, convenience, and expanded immunization capacity. Because no debate transcript or vote history is included, these concerns are inferred from the bill’s structure rather than documented opposition.